Doximity, Inc. Class A (DOCS)

Doximity's stock price declined significantly over the past six months, hitting a new 52-week low in March 2026. Key events include the February 2026 earnings report, which, despite exceeding estimates, led to a stock drop due to weak Q4 guidance and pharma delays attributed to 'Most Favored Nation' agreements. The company also initiated a $500 million share repurchase program and acquired Pathway Medical in July 2025.

While specific seasonality is not extensively outlined, Doximity has referred to 'traditional seasonality of the upfront and upsell seasons.' Delayed pharma bookings disrupted typical seasonal patterns at the end of 2025. Historically, August has been the strongest month for Doximity's stock, while October tends to be the weakest.

Doximity, Inc. operates as a digital platform for medical professionals in the United States, focusing on connecting clinicians, enhancing patient care, and fostering innovation. Its services include professional networking, curated medical news, telehealth tools like Doximity Dialer, career management, case collaboration, administrative paperwork streamlining, AI tools such as DoxGPT, marketing solutions, hiring solutions, and DocDefender, a service removing physicians' personal information from public websites.

Doximity, Inc. primarily operates within the United States, serving medical professionals across all 50 states and every medical specialty. Over 85% of U.S. physicians and two-thirds of nurse practitioners and physician assistants are members. The company is headquartered in San Francisco, California.

Doximity generally maintains a strong brand reputation, particularly for its telehealth offerings. Doximity Dialer was named the #1 Telehealth Video Conferencing Platform in the 2026 Best in KLAS Report for the fifth consecutive year. A Doximity study indicated rapid AI adoption by physicians, and the company launched DocDefender to protect physicians' personal information. However, in the past, there were concerns about misinformation on Doximity's news feed.

Doximity, Inc. has a significant institutional ownership presence, with approximately 76.47% to 90.29% of the stock held by institutional investors such as BlackRock, Inc. and Vanguard Group Inc. Insiders own a smaller percentage (approximately 2.12% to 2.66%), while public companies and individual investors hold approximately 10.69% to 20.87%.